| Robin Hogg, | |
|
11015 Ellenton St, Barnwell, SC 29812-7307 | |
| (803) 541-1061 | |
| Not Available |
| Full Name | Robin Hogg |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 11015 Ellenton St, Barnwell, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194142802 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | P21009 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robin Hogg, 11015 Ellenton St, Barnwell, SC 29812-7307 Ph: () - | Robin Hogg, 11015 Ellenton St, Barnwell, SC 29812-7307 Ph: (803) 541-1061 |
News Archive
Their study, which appears this week in the online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), may re-energize attempts to create a preventive/therapeutic vaccine against HIV, say the authors.
Iain Chapple, University of Birmingham, England, presented the oral session "Longitudinal Serological and Vaccination Responses to SARS-COV-2 in Dental Professionals" at the virtual 99th General Session & Exhibition of the International Association for Dental Research (IADR), held in conjunction with the 50th Annual Meeting of the American Association for Dental Research (AADR) and the 45th Annual Meeting of the Canadian Association for Dental Research (CADR), on July 21-24, 2021.
Professor William G. Kearns told the annual meeting of the European Society of Human Reproduction and Embryology that a three-day-old embryo with an incorrect number of chromosomes was capable of undergoing "a dynamic process of genetic normalisation" so that by day five, when it had developed to the blastocyst stage, it had become euploid, with the correct number of chromosomes.
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University and University Hospital Basel have now for the first time successfully combined such an antibody-drug conjugate with a therapy that stimulates the immune system to attack tumor cells.
› Verified 2 days ago
Kendra Lasha Harley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11015 Ellenton St, Barnwell, SC 29812 Phone: 803-541-1061 Fax: 803-541-1066 |